EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LPS-Induced Acute Lung Injury: Analysis of the Development and Suppression by the TNF-α-Targeting Aptamer

A V Sen'kova, I A Savin, E L Chernolovskaya, A S Davydova, M I Meschaninova, A Bishani, M A Vorobyeva, M A Zenkova

Acta Naturae · 21.08.2024 · 16 (2) · 61-71

DOI: 10.32607/actanaturae.27393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Naturae, online erschienen am 21.08.2024. Verfasst von A V Sen'kova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russian Federation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) is a specific form of lung inflammation characterized by diffuse alveolar damage, noncardiogenic pulmonary edema, as well as a pulmonary and systemic inflammation. The pathogenesis of ALI involves a cascade inflammatory response accompanied by an increase in the local and systemic levels of proinflammatory cytokines and chemokines. The development of molecular tools targeting key components of cytokine signaling appears to be a promising approach in ALI treatment. The development of lipopolysaccharide (LPS)-induced ALI, as well as the feasibility of suppressing it by an aptamer targeting the proinflammatory cytokine TNF-α, was studied in a mouse model. The TNF-α level was shown to increase significantly and remain steadily high during the development of ALI. LPS-induced morphological signs of inflammation in the respiratory system become most pronounced 24 h after induction. Intranasal administration of TNF-α-targeting aptamers conjugated with polyethylene glycol (PEG-aptTNF-α) to mice with ALI reduced the intensity of inflammatory changes in lung tissue. Assessment of the levels of potential TNF-α target genes (Usp18, Traf1, and Tnfaip3) showed that their expression levels in the lungs increase during ALI development, while declining after the application of PEG-aptTNF-α. Therefore, topical use of TNF-α-targeting aptamers may be an efficient tool for treating ALI and other inflammatory lung diseases.

Schlagwörter

Stichwörter der Autor:innen

acute lung injuryaptamersproinflammatory cytokinestarget genes

Autor:innen und Institutionen

  • Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090 Russian Federation.

Zitieren

APA

Sen'kova, A. V., Savin, I. A., Chernolovskaya, E. L., Davydova, A. S., Meschaninova, M. I., Bishani, A., Vorobyeva, M. A., & Zenkova, M. A. (2024). LPS-Induced Acute Lung Injury: Analysis of the Development and Suppression by the TNF-α-Targeting Aptamer. Acta Naturae, 16(2), 61-71. https://doi.org/10.32607/actanaturae.27393

Vancouver

Sen'kova AV, Savin IA, Chernolovskaya EL, Davydova AS, Meschaninova MI, Bishani A, et al. LPS-Induced Acute Lung Injury: Analysis of the Development and Suppression by the TNF-α-Targeting Aptamer. Acta Naturae. 2024;16(2):61-71. doi:10.32607/actanaturae.27393

BibTeX
@article{Senkova2024,
  author = {Sen'kova, A V and Savin, I A and Chernolovskaya, E L and Davydova, A S and Meschaninova, M I and Bishani, A and Vorobyeva, M A and Zenkova, M A},
  title = {LPS-Induced Acute Lung Injury: Analysis of the Development and Suppression by the TNF-α-Targeting Aptamer},
  journal = {Acta Naturae},
  year = {2024},
  volume = {16},
  number = {2},
  pages = {61--71},
  doi = {10.32607/actanaturae.27393}
}
Kostenlos starten →